LIM domain proteins Pinch1/2 regulate chondrogenesis and bone mass in mice

Abstract

The LIM domain-containing proteins Pinch1/2 regulate integrin activation and cell–extracellular matrix interaction and adhesion. Here, we report that deleting Pinch1 in limb mesenchymal stem cells (MSCs) and Pinch2 globally (double knockout; dKO) in mice causes severe chondrodysplasia, while single mutant mice do not display marked defects. Pinch deletion decreases chondrocyte proliferation, accelerates cell differentiation and disrupts column formation. Pinch loss drastically reduces Smad2/3 protein expression in proliferative zone (PZ) chondrocytes and increases Runx2 and Col10a1 expression in both PZ and hypertrophic zone (HZ) chondrocytes. Pinch loss increases sclerostin and Rankl expression in HZ chondrocytes, reduces bone formation, and increases bone resorption, leading to low bone mass. In vitro studies revealed that Pinch1 and Smad2/3 colocalize in the nuclei of chondrocytes. Through its C-terminal region, Pinch1 interacts with Smad2/3 proteins. Pinch loss increases Smad2/3 ubiquitination and degradation in primary bone marrow stromal cells (BMSCs). Pinch loss reduces TGF-β-induced Smad2/3 phosphorylation and nuclear localization in primary BMSCs. Interestingly, compared to those from single mutant mice, BMSCs from dKO mice express dramatically lower protein levels of β-catenin and Yap1/Taz and display reduced osteogenic but increased adipogenic differentiation capacity. Finally, ablating Pinch1 in chondrocytes and Pinch2 globally causes severe osteopenia with subtle limb shortening. Collectively, our findings demonstrate critical roles for Pinch1/2 and a functional redundancy of both factors in the control of chondrogenesis and bone mass through distinct mechanisms.

References

[1] Kronenberg HM Developmental regulation of the growth plate. Nature, 2003, 423:332-336

[2] Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol., 2012, 13:27-38

[3] Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int. J. Biochem. Cell Biol., 2008, 40:46-62

[4] Liu CF, Samsa WE, Zhou G, Lefebvre V. Transcriptional control of chondrocyte specification and differentiation. Semin. Cell Dev. Biol., 2017, 62:34-49

[5] Foster JW et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature, 1994, 372:525-530

[6] Wagner T et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell, 1994, 79:1111-1120

[7] Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev., 2002, 16:2813-2828

[8] Leung VY et al. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet., 2011, 7

[9] de Crombrugghe B et al. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol., 2000, 19:389-394

[10] Akiyama H et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev., 2004, 18:1072-1087

[11] Bell DM et al. SOX9 directly regulates the type-II collagen gene. Nat. Genet., 1997, 16:174-178

[12] Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell Biol., 1997, 17:2336-2346

[13] Lefebvre V, Li P, de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J., 1998, 17:5718-5733

[14] Ikegami D et al. Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development, 2011, 138:1507-1519

[15] Komori T et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 1997, 89:755-764

[16] Otto F et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell, 1997, 89:765-771

[17] Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997, 89:747-754

[18] Mundlos S et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell, 1997, 89:773-779

[19] Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev., 2001, 15:467-481

[20] Li F et al. Runx2 contributes to murine Col10a1 gene regulation through direct interaction with its cis-enhancer. J. Bone Min. Res, 2011, 26:2899-2910

[21] Zheng Q et al. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J. Cell Biol., 2003, 162:833-842

[22] Fujita T et al. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J. Cell Biol., 2004, 166:85-95

[23] Liao L et al. Deletion of Runx2 in articular chondrocytes decelerates the progression of DMM-induced osteoarthritis in adult mice. Sci. Rep., 2017, 7

[24] Tuli R et al. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J. Biol. Chem., 2003, 278:41227-41236

[25] Seo HS, Serra R. Deletion of Tgfbr2 in Prx1-cre expressing mesenchyme results in defects in development of the long bones and joints. Dev. Biol., 2007, 310:304-316

[26] Seo HS, Serra R. Tgfbr2 is required for development of the skull vault. Dev. Biol., 2009, 334:481-490

[27] Zhen G et al. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat. Med., 2013, 19:704-712

[28] van der Kraan, P. M., Blaney Davidson, E. N., Blom, A. & van den Berg, W. B. TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthr. Cartil. 17, 1539–1545 (2009).

[29] Blaney Davidson EN, van der Kraan PM, van den Berg WB. TGF-beta and osteoarthritis. Osteoarthr. Cartil., 2007, 15:597-604

[30] Loveridge N et al. The control of chondrocyte differentiation during endochondral bone growth in vivo: changes in TGF-beta and the proto-oncogene c-myc. J. Cell Sci., 1993, 105:949-956

[31] Yang X et al. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol., 2001, 153:35-46

[32] Ballock RT et al. TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev. Biol., 1993, 158:414-429

[33] Kang JS, Alliston T, Delston R, Derynck R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J., 2005, 24:2543-2555

[34] Li S et al. PINCH1 regulates cell-matrix and cell-cell adhesions, cell polarity and cell survival during the peri-implantation stage. J. Cell Sci., 2005, 118:2913-2921

[35] Liang X et al. PINCH1 plays an essential role in early murine embryonic development but is dispensable in ventricular cardiomyocytes. Mol. Cell Biol., 2005, 25:3056-3062

[36] Fukuda T, Chen K, Shi X, Wu C. PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J. Biol. Chem., 2003, 278:51324-51333

[37] Chen K et al. PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells. J. Biol. Chem., 2008, 283:2508-2517

[38] Xu H, Cao H, Xiao G. Signaling via PINCH: Functions, binding partners and implications in human diseases. Gene, 2016, 594:10-15

[39] Sakai T et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev., 2003, 17:926-940

[40] Stanchi F et al. Consequences of loss of PINCH2 expression in mice. J. Cell Sci., 2005, 118:5899-5910

[41] Tu Y, Li F, Goicoechea S, Wu C. The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol. Cell Biol., 1999, 19:2425-2434

[42] Meder B et al. PINCH proteins regulate cardiac contractility by modulating integrin-linked kinase-protein kinase B signaling. Mol. Cell Biol., 2011, 31:3424-3435

[43] Wu C. Integrin-linked kinase and PINCH: partners in regulation of cell-extracellular matrix interaction and signal transduction. J. Cell Sci., 1999, 112 Pt 24 4485-4489

[44] Chiswell BP, Zhang R, Murphy JW, Boggon TJ, Calderwood DA. The structural basis of integrin-linked kinase-PINCH interactions. Proc. Natl Acad. Sci. USA, 2008, 105:20677-20682

[45] Kogata N, Tribe RM, Fassler R, Way M, Adams RH. Integrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contraction. Genes Dev., 2009, 23:2278-2283

[46] Montanez E, Wickstrom SA, Altstatter J, Chu H, Fassler R. Alpha-parvin controls vascular mural cell recruitment to vessel wall by regulating RhoA/ROCK signalling. EMBO J., 2009, 28:3132-3144

[47] Akhtar N, Streuli CH. An integrin-ILK-microtubule network orients cell polarity and lumen formation in glandular epithelium. Nat. Cell Biol., 2013, 15:17-27

[48] Kovalevich J, Tracy B, Langford D. PINCH: more than just an adaptor protein in cellular response. J. Cell Physiol., 2011, 226:940-947

[49] Wang-Rodriguez J, Dreilinger AD, Alsharabi GM, Rearden A. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges. Cancer, 2002, 95:1387-1395

[50] Zhang JT et al. Up-regulation of PINCH in the stroma of oral squamous cell carcinoma predicts nodal metastasis. Oncol. Rep., 2005, 14:1519-1522

[51] Eke I et al. PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha. J. Clin. Investig., 2010, 120:2516-2527

[52] Komori, T. Cell death in chondrocytes, osteoblasts, and osteocytes. Int. J. Mol. Sci. 17, 2045 (2016).

[53] Weivoda MM, Youssef SJ, Oursler MJ. Sclerostin expression and functions beyond the osteocyte. Bone, 2017, 96:45-50

[54] Li X et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem., 2005, 280:19883-19887

[55] Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J. Biol. Chem., 2005, 280:26770-26775

[56] Kishimoto K, Kitazawa R, Kurosaka M, Maeda S, Kitazawa S. Expression profile of genes related to osteoclastogenesis in mouse growth plate and articular cartilage. Histochem. Cell Biol., 2006, 125:593-602

[57] Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J., 2001, 20:2254-2272

[58] Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell, 2004, 3:379-389

[59] Kartsogiannis V et al. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone, 1999, 25:525-534

[60] Guo L et al. Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ. J. Cell Biol., 2018, 217:1431-1451

[61] Wu C et al. Kindlin-2 controls TGF-beta signalling and Sox9 expression to regulate chondrogenesis. Nat. Commun., 2015, 6

[62] Liang X et al. Targeted ablation of PINCH1 and PINCH2 from murine myocardium results in dilated cardiomyopathy and early postnatal lethality. Circulation, 2009, 120:568-576

[63] Logan M et al. Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis, 2002, 33:77-80

[64] Chen M et al. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Genesis, 2007, 45:44-50

[65] Zhu K et al. Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy. J. Biol. Chem., 2015, 290:8081-8094

[66] Cao H et al. Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis. J. Biol. Chem., 2013, 288:30399-30410

[67] Bouxsein ML et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Min. Res., 2010, 25:1468-1486

[68] Gao, H. et al. Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2. JCI Insight 4, e128405 (2019).

[69] Cao H et al. Activating transcription factor 4 regulates osteoclast differentiation in mice. J. Clin. Investig., 2010, 120:2755-2766

[70] Xiao G et al. Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling. J. Biol. Chem., 2012, 287:21450-21460